Using the new hemostatic gelatin GELITA-SPON RAPID³ to treat parenchymatous organs – a clinical observation

English version

Autoři: P. Hromádka; J. Škach
Působiště autorů: Chirurgické centrum, Krajská nemocnice Liberec a. s., prim. MUDr. Peter Hromádka
Vyšlo v časopise: Rozhl. Chir., 2015, roč. 94, č. 5, s. 221-223.
Kategorie: Monotematický speciál - Původní práce

Zdroje

1. Cogbill TH, Moore EE, Jurkovich GJ, Feliciano DV, Morris JA, Mucha P. Severe hepatic trauma: a multi-center experience with 1335 liver injuries. J Trauma. 1988; 28:1433-1438.

2. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97(5): 1180-95.

3. Chemeler SB, Prato BS, Cox PM jr. et al. Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. Ann Thorac Surg 2002; 73(1): 138-42

4. Takács I, Wegmann J, Horváth S, Ferencz A, Ferencz S, Jávor S, Odermatt E, Rõth E, Weber G. Efficacy of different hemostatic devices for severe liver bleeding: a randomized controlled animal study. , Surg Innov. 2010 Dec;17(4):346-52.

5. Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007;24(4):288-93. Epub 2007 Jul 27

6. Kathirkamanathan Shanmuganathan, MD, Stuart E. Mirvis, MD, Robin Boyd-Kranis, MD, Tatsuyoshi Takada, MD, PhD , Thomas M. Scalea, MD. Nonsurgical Management of Blunt Splenic Injury: Use of CT Criteria to Select Patients for Splenic Arteriography and Potential Endovascular Therapy, October Radiology 2000, 217, 75-82